Repetitive Medication Scoring Combined with Ineligible Prescription Determination Method in Management of Chinese Patent Medicine in Pediatrics

Yuan Ronghui; Fu Penggao; Duan Jun; Xu Hong; Yuan Lijialong

doi:10.13407/j.cnki.jpp.1672-108X.2023.11.007

您当前的位置：

首页 >

文章列表页 >

Repetitive Medication Scoring Combined with Ineligible Prescription Determination Method in Management of Chinese Patent Medicine in Pediatrics

更新时间：2023-11-08

- Repetitive Medication Scoring Combined with Ineligible Prescription Determination Method in Management of Chinese Patent Medicine in Pediatrics
- Vol. 29, Issue 11, Pages: 23-25(2023)
- 作者机构：
  
  怀化市第一人民医院,湖南,怀化,418000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2023.11.007
  CLC：
- Published：2023，
  
  Published Online：10 November 2023，
扫描看全文
Yuan Ronghui, Fu Penggao, Duan Jun, et al. Repetitive Medication Scoring Combined with Ineligible Prescription Determination Method in Management of Chinese Patent Medicine in Pediatrics. [J]. 29(11):23-25(2023)
DOI：

Yuan Ronghui, Fu Penggao, Duan Jun, et al. Repetitive Medication Scoring Combined with Ineligible Prescription Determination Method in Management of Chinese Patent Medicine in Pediatrics. [J]. 29(11):23-25(2023) DOI： 10.13407/j.cnki.jpp.1672-108X.2023.11.007.

摘要

目的:评估我院儿科中成药重复用药情况并找出经济有效的选药方法

为管理儿科中成药用药提供参考。方法:采用改良的重复用药评分表对我院 215 例病例进行评分

并根据评分分为 5 组。再用无资格方案判定方法对各组病例进行评估

筛选出增量成本/ 效果值最优的评分组。结果:使用中成药的 215 例患儿中

婴幼儿(0~2 岁)比例最高(67. 4%)。重复用药百分比为 12. 6%

重复用药评分为 2 分的病例增量成本/ 效果值最小(-0. 003 5)。结论:评分为 2 分的病例中成药单位花费成本取得的效果最好。

Abstract

Objective: To assess the repetitive use of Chinese patent medicines in pediatrics of our hospital and identify economically effective methods of drug selection

so as to provide references for the management of Chinese patent medicines in pediatrics. Methods: Modified repetitive medication scoring table was used to score 215 patients in our hospital

and all patients were divided into five groups based on the scores. Ineligible prescription determination method was applied to evaluate each group of cases

the scoring group with the optimal incremental cost/ effectiveness ratio was screened. Results: Among the 215 pediatric patients with Chinese patent medicines

infants and young children (from 0 to 2 years) at 67. 4% took the lead. The percentage of repetitive medication was 12. 6%

and cases with repetitive medication score of 2 points had the smallest incremental cost/ effectiveness ratio (-0. 003

5). Conclusion: Cases with score of 2 points in the repetitive medication evaluation achieve the best effectiveness in terms of cost per unit of Chinese patent medicines.

关键词

中成药重复用药无资格方案儿童

Keywords

Chinese patent medicinesrepetitive medicationineligible prescriptionchildren

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of Adverse Drug Reactions Induced by Traditional Chinese Medicine Injections in 104 Children

Investigation on Information of Over-The-Counter Drug Instructions of Chinese Patent Medicines for Children

Retrospective Analysis of Application of Chinese Patent Medicines with Ingredients of Toxic Nature in a Children’s Hospital

Analysis of 36 Cases of Drug Poisoning in Children in a Grade III, Level A General Hospital andConsideration on Pharmaceutical Care

Application of Dexmedetomidine Combined with Hydromorphone Nasal Drip in Sedation of Mother-InfantSeparation before Adenoidectomy

Related Author

Xu Jian

Tang Zhihua

Wang Xin

Sun Yanyan

Chen Bo

Wang Xiaoling

Jin Min

Zhang Yanju

Related Institution

Shaoxing People’s Hospital, Zhejiang Shaoxing

Tianjin Children’ s Hospital

Beijing Children’s Hospital, Capital Medical University

Beijing Hospital of Integrated Traditional Chinese and Western Medicine

The Second People’ s Hospital of Anhui Wuhu, Anhui Wuhu

⁰